Conclusions Within an overall decline in HIV-TB co-infection there has been a change in the pattern of co-infection. A greater proportion of cases now occur in people with known HIV infection, and fewer HIV infections are diagnosed after TB diagnosis. This may be explained by more HIV testing, including in TB clinics, resulting in earlier HIV diagnosis. However, as the number of people with HIV in the UK increases, sustained success requires better management of latent TB infection to prevent the occurrence of TB disease in people diagnosed with HIV. Background Directly observed treatment (DOT) has been the standard of care for tuberculosis since the early 1990s. In England DOT is targeted at those considered to be at high risk of poor adherence and clinically complex patients. We report the first randomised controlled trial of smartphoneenabled video observation of treatment (VOT) for active tuberculosis compared to DOT. Methods Tuberculosis patients eligible for selective DOT in England were randomised to an offer of asynchronous VOT (daily remote observation using a smartphone app) or DOT (3 or 5 times weekly observation in community or clinic settings). Results 58% of 226 randomised patients had a history of homelessness, drug use, imprisonment, alcohol or mental health problems. Of the 112 patients randomised to an offer of VOT, 70% had over 80% of scheduled observations completed over two months (the primary outcome measure) compared to 31% of 114 patients randomised to an offer of DOT (p<0.001). The effect was, in part, due to 51% of those randomised to DOT having less than one week of observation (compared to 10% of those randomised to VOT), and so not starting treatment with their allocated regimen. VOT patients sustained high observation levels throughout treatment, whereas this declined rapidly in DOT patients. We estimate that observation of a six month course of treatment with daily VOT cost £1645 per patient compared to £5700 for five times per week DOT. Conclusions VOT is a more effective and cheaper approach to observation of tuberculosis treatment than clinic or community based DOT. In England (73%) of TB cases occur among foreign-born individuals due to reactivation of Latent TB infection (LTBI).
1
The cornerstone of the global strategy to eliminate TB in low-incidence countries is to target preventative therapy at high-risk groups of developing active disease. England is the first country implementing a £10 m/annum program to systematically provide LTBI screening and treatment for new entrant migrants.
2 The main challenge is how to identify migrants eligible for screening among the reservoir of migrants already registered and those unregistered with primary-care. We aimed to establish the most feasible and effective method to localise migrants eligible for LTBI screening and to estimate population size, TB incidence after arrival and LTBI service utilisation of the target population. We performed a retrospective population based cohort study of VISA-applicants aged 16 to 35 years screened for active TB before entry to UK in 72 high-burden countries between 2011 and 2014. We used data record linkage of the pre-entry screening, the NHS Personal Demographic Service (PDS), the Enhanced TB Surveillance system and LTBI service utilisation databases. 1 93 979 migrants eligible for LTBI screening entered the UK between 2011 and 2014. A low proportion 78 395 (40.4%) registered in primary-care in the year of arrival, of whom 30 838 (39.3%) registered in high TB incidence areas of London and Midlands. We estimated the number of delayed registrations of the same age group in these areas by record linkage;
